U.S. issues new warning on J&J vaccine

U.S. issues new warning on J&J vaccine

the u.s food and drug administration warns johnson and johnson’s coffee 19 vaccine can lead to an increased risk of a rare neurological condition here’s the full story the u.s food and drug administration issued a warning for johnson and johnson’s covid19 vaccine saying data suggests an increased risk of a rare autoimmune disorder called keonbare also known as gbs the syndrome is a rare neurological condition in which the body’s immune system attacks the protective coating on nerve fibers most people fully recover in a monday letter to the company the fda said the chances of getting gbs was quote very low but still warns that recipients of the j j vaccine should seek medical attention if they show symptoms within six weeks of inoculation including weakness tingling sensations difficulty walking or difficulty with facial movements most cases were in men over the age of 50. nearly 13 million people have received j and j’s one dose vaccine in the u.s out of 100 preliminary reports of gbs the fda says 95 cases have required hospitalization and one death has been reported the warning is another setback for the j j shot as its one dose system was supposed to help vaccinate hard to reach areas last week european regulators issued a similar warning for astrazeneca’s vaccine which uses technology like j j’s a traditional virus-based approach meanwhile the fda has not linked gbs to the mrna vaccines pfizer bioattack and moderna u.s health officials are pushing back on pfizer’s request for the approval of a booster shot further covid19 vaccine the u.s health department and human services said the officials reiterated their position fully vaccinated americans do not need to get a booster shot pfizer had asserted a third dose of its vaccine would be needed within 12 months based on evidence of greater risk of reinfection six months after inoculation it also cited the spread of the highly contagious delta covid variant as another reason the world health organization warns about the dangers of mixing and matching of 19 vaccines of different brands we have this report people who are thinking about mixing and matching the world health organization’s chief scientist on monday advised against people mixing and matching covet 19 vaccines from different manufacturers calling it a dangerous trend since there is very little information on doing so so it’s a little bit of a dangerous trend here where people are evidence-free zone as far as a mix and match there is limited data on mix and match it will be a chaotic situation in countries if citizens start you know deciding when and who they should be taking a second or a third or a fourth dose dr somia swaminathan made her comments during the who’s latest online briefing infectious disease experts are weighing whether people who received johnson and johnson’s single-dose vaccine should receive a booster of the pfizer or moderna mrna-based vaccine which are said to be more effective against the highly contagious delta variant one of those who did mix and match is dr angela rasmussen a researcher at the university of saskatchewan’s vaccine and infectious disease organization who made headlines after she said on twitter that she had gotten a dose of pfizer’s vaccine in june after receiving j j’s in april she also advised other j j recipients especially those living in areas with low vaccination rates to talk to their doctors about doing the same separately pfizer is pushing u.s and european regulators to authorize a third booster shot to supplement its two-dose regimen but health officials including the who’s swaminathan have said there is no medical evidence that a third pfizer shot is necessary has to be based on the science and the data not on individual companies instead of offering booster shots to highly vaccinated wealthy nations the who’s director general on monday said companies like pfizer should send those vaccines to the who to give to poorer countries whose unvaccinated citizens desperately need them against a delta variant he described as quote ripping around the world at a scorching pace the who’s kovacs program plans to buy up to 550 million doses of chinese coveted 19 vaccines by the first half of 2022 gavi the co-lead of the program says it has signed advanced purchase agreements with sino farm and synovac under the deal the companies will provide 110 million vaccine doses by the end of october cavia also has the option to purchase more than fourth quarter of this year and in the first half of next year the agreement which comes at a time when the delta variant poses a rising risk is aimed at alleviating the current shortage of vaccines in developing countries
rn

U.S. issues new warning on J&J vaccine

rn

Share this post

Leave a Reply

Your email address will not be published. Required fields are marked *